HYSTERORESECTOSCOPY AS A STRATEGY FOR INCREASING THE CHANCES OF EMBRYO IMPLANTATION IN WOMEN WITH POLYCYSTIC OVARY SYNDROME AND METABOLIC SYNDROME
DOI:
https://doi.org/10.11603/2414-4533.2025.3.15670Keywords:
infertility, hysteroresectoscopy, polycystic ovary syndrome, metabolic syndrome, endometrium, in vitro fertilization, assisted reproductive technologies, endometrial hyperplasia, implantationAbstract
The aim of the work: the aim of the study was to evaluate the effect of pre-pregnancy metabolic optimization and operative hysteroresectoscopy before embryo transfer on the condition of the endometrium and in vitro fertilization (IVF) results in patients with polycystic ovary syndrome (PCOS) and metabolic syndrome (MS), in particular on the frequency of implantation and clinical pregnancies.
Materials and Methods. The study included 128 women of reproductive age with PCOS, divided into three groups: 1st – PCOS+MS, routine pre-protocol preparation; 2nd – PCOS+MS, metabolic optimization 8–12 weeks before the IVF program; 3rd – control, PCOS without MS. The indications for hysteroscopy were ultrasound and clinical signs of intrauterine pathology, thin or heterogeneous endometrium, repeated failed implantations, suspicion of chronic endometritis. The procedure was performed in the early proliferative phase with removal of detected formations, targeted biopsy, and subsequent morphological/immunohistochemical examination.
Results. Hysteroscopy was indicated in 42.2 % of patients, mainly in the PCOS+MS group without metabolic optimization. Hysteroscopy most often revealed endometrial polyps (up to 37.5 % in group 1) and simple hyperplasia without atypia (up to 25 %), less often proliferation disorders, signs of endometritis, and micropolyposis. In the group with pre-pregnancy optimization, the frequency of clinical pregnancies was 8.0% higher than in the routine preparation group and 5.7 % higher than in the control group; the live birth rate exceeded these figures by 10.5 % and 6.2 %, respectively. Although no statistically significant differences were found, there is a clinically significant trend toward improved IVF outcomes.
Conclusions. Women with PCOS, especially when combined with metabolic syndrome, often experience endometrial changes that reduce the effectiveness of IVF programs. The combination of pre-pregnancy metabolic optimization with operative hysteroscopy before embryo transfer improves the condition of the endometrium and has shown a tendency to increase the frequency of clinical pregnancies and live births.
References
Palomba S, Costanzi F, Caserta D, Vitagliano A. Pharmacological and non-pharmacological interventions for improving endometrial receptivity in infertile patients with polycystic ovary syndrome: a comprehensive review of the available evidence. Reprod Biomed Online. 2024 Dec.; 49(6):104381. DOI: 10.1016/j.rbmo.2024.104381. Epub. 2024 Jul. 20. PMID: 39454320. DOI: https://doi.org/10.1016/j.rbmo.2024.104381
Guo Y, Yang J, Chen H, Zhou Y, Yang Y, Wang B, Zha L, Bai D, Li W, Tang X, Fang Z, Li F, Jin L. Enhancing understanding of endometrial function in patients with PCOS: clinical and immunological insights. J Ovarian Res. 2025 Mar. 12; 18(1):52. DOI: 10.1186/s13048-025-01638-x. PMID: 40075432; PMCID: PMC11900192. DOI: https://doi.org/10.1186/s13048-025-01638-x
Mahabamunuge J, Sekula NM, Lepore C, Kudrimoti M, Upadhyay A, Alshowaikh K, Li HJ, Seifer DB, AlAshqar A. The Molecular Basis of Polycystic Ovary Syndrome and Its Cardiometabolic Correlates: Exploring the Intersection and Its Clinical Implications-A Narrative Review. Biomedicines. 2025 Mar. 13; 13(3):709. DOI: 10.3390/biomedicines13030709. PMID: 40149685; PMCID: PMC11940587. DOI: https://doi.org/10.3390/biomedicines13030709
Opuchlik K, Pankiewicz K, Pierzyński P, Sierdziński J, Aleksejeva E, Salumets A, Issat T, Laudański P. Factors influencing endometrial receptivity in women with recurrent implantation failure. BMC Womens Health. 2025 Jan. 9; 25(1):15. DOI: 10.1186/s12905-024-03531-z. PMID: 39789542; PMCID: PMC11715555. DOI: https://doi.org/10.1186/s12905-024-03531-z
Vaz GQ, Evangelista AV, Sartorio CA, Cardoso MC, Erthal MC, Gallo P, Oliveira MA. Are Patients with Polycystic Ovarian Syndrome Ideal Candidates for Oocyte Donation? Biomed Res Int. 2016; 2016:5701609. DOI: 10.1155/2016/5701609. Epub. 2016 Apr. 12. PMID: 27190994; PMCID: PMC4844867. DOI: https://doi.org/10.1155/2016/5701609
Albu A, Albu D. Endometrial Receptivity in Patients with Polycystic Ovary Syndrome [Internet]. Infertility and Assisted Reproduction. IntechOpen; 2021. DOI: 10.5772/intechopen.98624 DOI: https://doi.org/10.5772/intechopen.98624
Lessey BA, Young SL. What exactly is endometrial receptivity? Fertility and Sterility. 2019; 111(4):611-17. DOI: 10.1016/j.fertnstert.2019.02.009. DOI: https://doi.org/10.1016/j.fertnstert.2019.02.009
Harper Claire. Increased levels of testosterone associated with polycystic ovary syndrome (PCOS) negatively affect HOXA10 and integrin b3 expression in endometrial cells and embryo attachment using a trophoblast cell spheroid model. 2022. Abstract from Maternal Health Research Conference. DOI: 10.1530/endoabs.77.p236. DOI: https://doi.org/10.1530/endoabs.77.P236
Ozen F, Kaya-Sezginer E, Kırlangıc O, Tekeli Taskomur A, Aktan F, Kaplan G, Ozgurtas T. Vascular endothelial growth factor (VEGF)-C and its receptors, soluble VEGFR-2 and VEGFR-3, in polycystic ovary syndrome. Turkish Journal of Biochemistry. 2024; 49(2):266-73. DOI: 10.1515/tjb-2023-0202. DOI: https://doi.org/10.1515/tjb-2023-0202
Enciso M, Aizpurua J, Rodríguez-Estrada B, Jurado I, Ferrández-Rives M, Rodríguez E, Pérez-Larrea E, Climent AB, Marron K, Sarasa J. The precise determination of the window of implantation significantly improves ART outcomes. Sci Rep. 2021 Jun. 28; 11(1):13420. DOI: 10.1038/s41598-021-92955-w. PMID: 34183760; PMCID: PMC8238935. DOI: https://doi.org/10.1038/s41598-021-92955-w
Li F, Qi JJ, Li LX, Yan TF. Impact of insulin resistance on IVF/ICSI outcomes in women with polycystic ovary syndrome: A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2024 Aug.; 299:54-61. DOI: 10.1016/j.ejogrb.2024.05.042. Epub. 2024 Jun. 3. PMID: 38838387. DOI: https://doi.org/10.1016/j.ejogrb.2024.05.042
Zhang D, Yang X, Li J, Yu J, Wu X. Effect of hyperinsulinaemia and insulin resistance on endocrine, metabolic and fertility outcomes in women with polycystic ovary syndrome undergoing ovulation induction. Clin Endocrinol (Oxf). 2019 Sep.; 91(3):440-48. DOI: 10.1111/cen.14050. Epub. 2019 Jun. 28. PMID: 31222771. DOI: https://doi.org/10.1111/cen.14050
Sun YF, Zhang J, Xu YM, Cao ZY, Wang YZ, Hao GM, Gao BL. High BMI and Insulin Resistance Are Risk Factors for Spontaneous Abortion in Patients With Polycystic Ovary Syndrome Undergoing Assisted Reproductive Treatment: A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne). 2020 Dec. 3; 11:592495. DOI: 10.3389/fendo.2020.592495. PMID: 33343510; PMCID: PMC7744738. DOI: https://doi.org/10.3389/fendo.2020.592495
Ticconi C, Inversetti A, Marraffa S, Campagnolo L, Arthur J, Zambella E, Di Simone N. Chronic endometritis and recurrent reproductive failure: a systematic review and meta-analysis. Front Immunol. 2024 Aug. 16; 15:1427454. DOI: 10.3389/fimmu.2024.1427454. PMID: 39286255; PMCID: PMC11403846. DOI: https://doi.org/10.3389/fimmu.2024.1427454
Amrani M, Renné C, Blaschke V, Schlautmann E, Schaffrath M, Linek B, Skala C, Schepers M, Brenner W. Chronic endometritis identified by plasma cells can often be diagnosed in patients with recurrent implantation failure. Eur J Obstet Gynecol Reprod Biol. 2025 Aug; 312:114092. DOI: 10.1016/j.ejogrb.2025.114092. Epub. 2025 Jun 3. PMID: 40482406. DOI: https://doi.org/10.1016/j.ejogrb.2025.114092
Van Hoogenhuijze NE, Lahoz Casarramona G, Lensen S, Farquhar C, Kamath MS, Kunjummen AT, Raine-Fenning N, Berntsen S, Pinborg A, Mackens S, Inal ZO, Ng EHY, Mak JSM, Narvekar SA, Martins WP, Steengaard Olesen M, Torrance HL, Mol BW, Eijkemans MJC, Wang R, Broekmans FJM. Endometrial scratching in women undergoing IVF/ICSI: an individual participant data meta-analysis. Hum Reprod Update. 2023 Nov. 2; 29(6):721-40. DOI: 10.1093/humupd/dmad014. PMID: 37336552; PMCID: PMC10628489. DOI: https://doi.org/10.1093/humupd/dmad014
Wang Y, Tang Z, Wang C, Teng X, He J. Whether hysteroscopy improves fertility outcomes in infertile women: a meta-analysis and systematic review. Front Endocrinol (Lausanne). 2024 Dec. 16; 15:1489783. DOI: 10.3389/fendo.2024.1489783. PMID: 39736864; PMCID: PMC11683682. DOI: https://doi.org/10.3389/fendo.2024.1489783
Navali N, Kazemi ES, Azizi H, Hakimi P, Eghbali E. Comparison and correlations between findings of hysteroscopy and vaginal color Doppler ultrasonography for detection of uterine abnormalities in patients with recurrent implantation failure. Open Med (Wars). 2025 Jun. 13; 20(1):20251226. DOI: 10.1515/med-2025-1226. PMID: 40534632; PMCID: PMC12176008. DOI: https://doi.org/10.1515/med-2025-1226
Rani K, Durga Mounika K, Singhal S. Correlation of Hysteroscopy With Histopathological Findings of the Endometrium in Women With Polycystic Ovary Syndrome (PCOS)-Related Infertility. Cureus. 2024 Apr. 5; 16(4):e57666. DOI: 10.7759/cureus.57666. PMID: 38707142; PMCID: PMC11070178. DOI: https://doi.org/10.7759/cureus.57666
Saponara S, Angioni S, Parry JP, Pacheco LA, Carugno J, Moawad N, Haimovich S, Lasmar RB, Dealberti D, Aksakal E, Urman B, Nappi L, Vitale SG. The Pivotal role of hysteroscopy in diagnosing subtle uterine lesions in infertile patients: Seeing the unseen can make the difference. Eur J Obstet Gynecol Reprod Biol. 2025 Feb.; 305:132-41. DOI: 10.1016/j.ejogrb.2024.12.013. Epub. 2024 Dec. 9. PMID: 39701007. DOI: https://doi.org/10.1016/j.ejogrb.2024.12.013
Unfer V, Nestler JE, Kamenov ZA, Prapas N, Facchinetti F. Effects of Inositol(s) in Women with PCOS: A Systematic Review of Randomized Controlled Trials. Int J Endocrinol. 2016; 2016:1849162. DOI: 10.1155/2016/1849162. Epub. 2016 Oct. 23. PMID: 27843451; PMCID: PMC5097808. DOI: https://doi.org/10.1155/2016/1849162
Genazzani AD. Inositol as putative integrative treatment for PCOS. Reprod Biomed Online. 2016 Dec.; 33(6):770-80. DOI: 10.1016/j.rbmo.2016.08.024. Epub 2016 Sep 16. PMID: 27717596. DOI: https://doi.org/10.1016/j.rbmo.2016.08.024
ESHRE Working Group on Recurrent Implantation Failure; Cimadomo D, de Los Santos MJ, Griesinger G, Lainas G, Le Clef N, McLernon DJ, Montjean D, Toth B, Vermeulen N, Macklon N. ESHRE good practice recommendations on recurrent implantation failure. Hum Reprod Open. 2023 Jun. 15; 2023(3):hoad023. DOI: 10.1093/hropen/hoad023. PMID: 37332387; PMCID: PMC10270320. DOI: https://doi.org/10.1093/hropen/hoad023
Practice Committee of the American Society for Reproductive Medicine. Electronic address: asrm@asrm.org; Practice Committee of the American Society for Reproductive Medicine. Fertility evaluation of infertile women: a committee opinion. Fertil Steril. 2021 Nov.; 116(5):1255-65. DOI: 10.1016/j.fertnstert.2021.08.038. Epub. 2021 Oct. 2. PMID: 34607703. DOI: https://doi.org/10.1016/j.fertnstert.2021.08.038
Mao X, Wu L, Chen Q, Kuang Y, Zhang S. Effect of hysteroscopy before starting in-vitro fertilization for women with recurrent implantation failure: A meta-analysis and systematic review. Medicine (Baltimore). 2019 Feb.; 98(7):e14075. DOI: 10.1097/MD.0000000000014075. PMID: 30762725; PMCID: PMC6408091. DOI: https://doi.org/10.1097/MD.0000000000014075
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 С. В. ХМІЛЬ, Ю. Б. ПРАВАК

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish their work in Hospital Surgery. Journal by L. Ya. Kovalchuk agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).